Ipca Laboratories Limited demonstrates a strong falling trendline breakout on the daily chart, advancing to Rs 1,953.30 (+2.62%).
Virat Jagad, Sr Technical Research Analyst, at Bonanza PortfolioDisclosure: This article has been written by Podishetti Akash, who is not a SEBI-registered Research Analyst or an Investment Adviser.
Podishetti Akash and his ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication.
The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution.
Readers are advised to consider the original research report and make their investment decisions based on their own assessment.
Ipca Laboratories Limited demonstrates a strong falling trendline breakout on the daily chart, advancing to Rs 1,953.30 (+2.62%). Holding firmly above its key moving average cluster with supportive trading volume and a bullish RSI recovery crossing past signal lines to 54.92, the setup confirms accelerated upside momentum toward Rs 2,130.
Virat Jagad, Sr Technical Research Analyst, at Bonanza Portfolio
Disclosure: This article has been written by Podishetti Akash, who is not a SEBI-registered Research Analyst or an Investment Adviser. Podishetti Akash and his ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclosures here.
